2. Search Result
Search Result
Results for "

racemic mixture

" in MedChemExpress (MCE) Product Catalog:

73

Inhibitors & Agonists

2

Peptides

7

Natural
Products

8

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-131904
    POMHEX
    3 Publications Verification

    		 Enolase Apoptosis Metabolic Disease Cancer
    POMHEX, a racemic mixture and a cell-permeable pivaloyloxymethyl (POM) proagent of HEX, is a potent, ENO2-specific inhibitor of enolase. POMHEX exhibits low-nanomolar potency against ENO1-deleted cells in vitro and is capable of eradicating ENO1-deleted xenografted tumours in vivo. POMHEX is a potent glycolysis inhibitor .
    POMHEX
  • HY-134818
    ML-SI1
    Maximum Cited Publications
    6 Publications Verification

    		 TRP Channel Neurological Disease
    ML-SI1, a racemic mixture of diastereomers, is a TRPML inhibitor with an IC50 value of 15 μM for TRPML1 .
    ML-SI1
  • HY-B2236
    DL-Lysine

    (±)-2,6-Diaminocaproic acid

    		 Endogenous Metabolite Metabolic Disease
    DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins .
    DL-Lysine
  • HY-N7142S
    DL-Norepinephrine-d6 hydrochloride

    		Adrenergic Receptor Neurological Disease Metabolic Disease
    DL-Norepinephrine-d6 hydrochloride is the deuterium labeled DL-Norepinephrine hydrochloride. DL-Norepinephrine hydrochloride is an external racemic catecholamine neurotransmitter, which is an equal mixture of the left-handed (L-, with activity) and right-handed (D-, with very low or no activity) stereoisomers. DL-Norepinephrine hydrochloride after being labeled with tritium can be used as a tracer for the research on Parkinson's disease .
    DL-Norepinephrine-d6 hydrochloride
  • HY-110406A
    (±)13-HpODE
    1 Publications Verification

    13-Hydroperoxylinoleic acid; Linoleic acid 13-hydroperoxide

    		 Endogenous Metabolite Others
    (±)13-HpODE (13-hydroperoxylinoleic acid) is a racemic mixture of hydroperoxides, which is produced by the oxidation of linoleic acid by lipoxygenase .
    (±)13-HpODE
  • HY-118590
    ICRF-193
    2 Publications Verification

    		 Topoisomerase DNA/RNA Synthesis Apoptosis Fungal Infection Cardiovascular Disease Inflammation/Immunology Cancer
    ICRF-193 is a DNA Topoisomerase II inhibitor. (S,S)- and (R,R)-isomers ICRF-193 make up an racemic mixture, ICRF-196 (HY-118590A). ICRF-193 can inhibit DNA syntheses and induces apoptosis. ICRF-193 exhibits anti-cancer and anti-inflammation effects. ICRF-193 shows cardioprotective effect against anthracycline toxicity to cardiomyocytes. ICRF-193 can be used for the researches of cancer, infection, inflammation and cardiovascular disease, such as acute promyelocytic leukemia .
    ICRF-193
  • HY-103019A
    (±)-Enitociclib

    (±)-BAY-1251152; (±)-VIP152

    		 CDK Apoptosis DNA/RNA Synthesis Cancer
    (±)-Enitociclib ((±)-BAY-1251152) is the racemic mixture of Enitociclib (HY-103019E). Enitociclib is a selective CDK9 inhibitor and apoptosis inducer. Enitociclib inhibits CDK9 activity and reduces the phosphorylation of Ser2 in the carboxyl-terminal domain (CTD) of RNA polymerase Pol II, thereby downregulating the transcription of key oncogenes such as MYC and MCL1. Enitociclib has anti-proliferative activity targeting MYC + lymphoma and multiple myeloma (MM) cells, and has synergistic effects with Bortezomib (HY-10227) and Lenalidomide (HY-A0003), and can be used in the research of hematological malignancies .
    (±)-Enitociclib
  • HY-14545
    Amisulpride
    2 Publications Verification

    (Rac)-Aramisulpride; (Rac)-Esamisulpride; DAN 2163

    		 Dopamine Receptor 5-HT Receptor Neurological Disease
    Amisulpride ((Rac)-Aramisulpride) is a racemic (50:50) mixture of the R-Amisulpride (HY-109167) and S-Amisulpride (HY-126068). Amisulpride is a dopamine D2/D3 receptor antagonist with Ki values of 2.8 and 3.2 nM for human dopamine b>D2 and b>D3, respectively. Amisulpride is a 5-HT7 receptor antagonist with a Ki of 44 nM. Amisulpride can be used in psychiatric research .
    Amisulpride
  • HY-Y1315
    DL-Tartaric acid
    1 Publications Verification

    		 Biochemical Assay Reagents Endocrinology
    DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity. 14C-labeled DL-Tartaric acid is nephrotoxic .
    DL-Tartaric acid
  • HY-N7142
    DL-Norepinephrine hydrochloride
    2 Publications Verification

    		 Adrenergic Receptor Neurological Disease
    DL-Norepinephrine hydrochloride is an external racemic catecholamine neurotransmitter, which is an equal mixture of the left-handed (L-, with activity) and right-handed (D-, with very low or no activity) stereoisomers. DL-Norepinephrine hydrochloride after being labeled with tritium can be used as a tracer for the research on Parkinson's disease .
    DL-Norepinephrine hydrochloride
  • HY-135026
    DL-Norepinephrine tartrate
    2 Publications Verification

    		 Adrenergic Receptor Neurological Disease
    DL-Norepinephrine tartrate is an external racemic catecholamine neurotransmitter, which is an equal mixture of the left-handed (L-, with activity) and right-handed (D-, with very low or no activity) stereoisomers. DL-Norepinephrine tartrate after being labeled with tritium can be used as a tracer for the research on Parkinson's disease .
    DL-Norepinephrine tartrate
  • HY-137258
    (±)-N-3-Benzylnirvanol

    		Cytochrome P450 Metabolic Disease
    (±)-N-3-Benzylnirvanol is a racemic mixture of (+)-N-3-Benzylnirvanol and (-)-N-3-Benzylnirvanol. (+)-N-3-Benzylnirvanol and (–)-N-3-Benzylnirvanol are potent and selective cytochrome P450 inhibitors with Ki values of 0.25 and 5.3 μM for CYP2C19, respectively .
    (±)-N-3-Benzylnirvanol
  • HY-W012908
    DL-Proline

    		Biochemical Assay Reagents Infection Cancer
    DL-Proline is a racemic mixture of D-Proline and L-Prolin. DL-Proline is a cyclic imino acid with a five-membered ring structure. DL-Proline is a key structural unit in peptide synthesis. DL-Proline can stabilize the β-turn conformation and affect the secondary structure of the peptide. DL-Proline has biological activities such as regulating peptide conformation and enhancing the stability of cyclic peptides. DL-Proline can be used to study diseases related to peptide structure and function, such as cancer and bacterial infection .
    DL-Proline
  • HY-113764
    N-Butanoyl-DL-homoserine lactone

    (Rac)-C4-HSL

    		 Bacterial Infection Inflammation/Immunology
    N-Butanoyl-DL-homoserine lactone ((Rac)-C4-HSL) is a racemic mixture of N-Butanoyl-D-homoserine lactone and N-Butanoyl-L-homoserine lactone. N-Butanoyl-L-homoserine lactone is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone has antibacterial activity and is used in antibacterial biofilm. N-Butanoyl-L-homoserine lactone aptamers blocks qurom sensing and inhibits biofilm formation in Pseudomonas aeruginosa .
    N-Butanoyl-DL-homoserine lactone
  • HY-173630A
    (Rac)-BMS-986449

    		Molecular Glues IKZF Family Cancer
    (R)-BMS-986449 is the racemic mixture of BMS-986449 (HY-173630). BMS-986449 is a CELMoD molecular glue and an IKZF2/IKZF4 degrader. BMS-986449 targets the degradation of transcription factors Helios (IKZF2) and Eos (IKZF4) in regulatory T (Treg) cells. BMS-986449 redirects the E3 ubiquitin ligase Cereblon to induce the degradation of Helios and Eos, reprogramming Treg cells and enhancing antitumor immunity. BMS-986449 is promising for research of advanced solid tumors .
    (Rac)-BMS-986449
  • HY-15997
    (-)-U-50488 hydrochloride
    1 Publications Verification

    (-)-Trans-(1S,2S)-U-50488 hydrochloride

    		 Opioid Receptor Infection Cancer
    (-)-U-50488 hydrochloride ((-)-Trans-(1S,2S)-U-50488 hydrochloride) is a selective kappa-opioid receptor (KOR) agonist (b>Kd=2.2 nM) over μ-opioid receptor (MOR) (b>Kd=430 nM). (-)-U-50488 hydrochloride is a more active enantiomer than (+)?trans-(1R,2R) U-50488 (HY-15997A)?or the (±)?trans-racemic mixture U-50488 (HY-15997B). (-)-U-50488 hydrochloride has a potent and sustained anti-HIV effect in fected blood monocyte-derived macrophages (MDM) .
    (-)-U-50488 hydrochloride
  • HY-15997B
    (±)-U-50488 hydrochloride

    (±)-Trans-(1R,2R)-U-50488 hydrochloride

    		 Opioid Receptor Neurological Disease
    (±)-U-50488 ((±)-Trans-(1R,2R)-U-50488) hydrochloride is a selective κ opioid receptor (KOR) agonist .
    (±)-U-50488 hydrochloride
  • HY-W041895
    DL-Glutamic acid

    		Endogenous Metabolite DNA/RNA Synthesis Bacterial Infection
    DL-Glutamic acid is a racemic amino acid mixture and an antibacterial agent. DL-Glutamic acid reduces RNA and DNA levels, with a more significant effect on RNA. DL-Glutamic acid inhibits cell division of Rhodospirillum rubrum .
    DL-Glutamic acid
  • HY-100841
    (Rac)-3-Hydroxyphenylglycine

    3HPG

    		 mGluR Neurological Disease
    (Rac)-3-Hydroxyphenylglycine (3HPG) is a racemic mixture of (S)-3-hydroxyphenylglycine and (R)-3-hydroxyphenylglycine. (S)-3-Hydroxyphenylglycine is a potent and selective mGluR1 agonist .
    (Rac)-3-Hydroxyphenylglycine
  • HY-N7142S3
    DL-Norepinephrine-d6

    		Isotope-Labeled Compounds Adrenergic Receptor Cardiovascular Disease Neurological Disease
    DL-Norepinephrine-d6 is the deuterium labeled DL-Norepinephrine. DL-Norepinephrine is an external racemic catecholamine neurotransmitter, which is an equal mixture of the left-handed (L-, with activity) and right-handed (D-, with very low or no activity) stereoisomers. DL-Norepinephrine after being labeled with tritium can be used as a tracer for the research on Parkinson's disease .
    DL-Norepinephrine-d6
  • HY-135113
    DL/meso-Lanthionine

    		Amino Acid Derivatives Others
    DL/meso-Lanthionine is a mixture of the racemic mixture (DL-) and meso- isomers of Lanthionine. Lanthionine is a non-protein amino acid composed of two alanine residues cross-linked by a thioether bond and is a structural component of the bacterial cell wall.
    DL/meso-Lanthionine
  • HY-130319A
    9-HEPE

    		PPAR Cardiovascular Disease Metabolic Disease
    9-HEPE, a oxidation product of Eicosapentaenoic acid, is a racemic mixture of 9(R)-HEPE and 9(S)-HEPE. 9-HEPE induces fatty acid oxidation, adipogenesis, and glucose uptake via activation of PPARs in vivo .
    9-HEPE
  • HY-116663
    (±)20-HDHA

    (±)20-HDoHE

    		 Endogenous Metabolite Neurological Disease
    (±)20-HDHA ((±)20-HDoHE) is a racemic mixture and is an autoxidation product of Docosahexaenoic acid (DHA). (±)20-HDHA is also formed by peroxidation process in human platelets and rat brain homogenate .
    (±)20-HDHA
  • HY-178193A
    (Rac)-Chem-0199

    		DNA/RNA Synthesis Akt PD-1/PD-L1 Cancer
    (Rac)-Chem-0199 is the racemic mixture of Chem-0199 (HY-178193). Chem-0199 is an Adipocyte Enhancer-Binding Protein 1 (AEBP1) inhibitor. Chem-0199 can disrupt the interaction between AEBP1 and CKAP4, thereby enhances antitumor immunity. Chem-0199 can inhibit Akt phosphorylation (p-Akt) and downregulates PD-L1 expression. Chem-0199 can be used for the research of cancer, such as colon cancer .
    (Rac)-Chem-0199
  • HY-15997C
    (±)-U-50488 hydrate hydrochloride

    (±)-Trans-(1R,2R)-U-50488 hydrate hydrochloride

    		 Opioid Receptor Neurological Disease
    (±)-U-50488 ((±)-Trans-(1R,2R)-U-50488) hydrate hydrochloride is a selective κ opioid receptor (KOR) agonist .
    (±)-U-50488 hydrate hydrochloride
  • HY-151525A
    (R,S)-YAP-TEAD-IN-2

    		YAP Cancer
    (R,S)-YAP-TEAD-IN-2 is the racemic mixture of YAP-TEAD-IN-2 (HY-151525). YAP-TEAD-IN-2 (Compound 6) is a potent inhibitor of YAP-TEAD PPIs (protein-protein interaction) with an IC50 of 2.7 nM .
    (R,S)-YAP-TEAD-IN-2
  • HY-121987A
    (±)15-HEDE

    		Lipoxygenase Inflammation/Immunology
    (±)15-HEDE is a racemic mixture of the monohydroxy fatty acids 15(R)-HEDE and 15(S)-HEDE. 15-HEDE is formed from eicosadienoic acid in macrophages. It inhibits 5-lipoxygenase (5-LO; IC50=35 μM).
    (±)15-HEDE
  • HY-N7142S1
    DL-Norepinephrine-d3 hydrochloride

    		Adrenergic Receptor Neurological Disease
    DL-Norepinephrine-d3 hydrochloride is the deuterium labeled DL-Norepinephrine hydrochloride. DL-Norepinephrine hydrochloride is an external racemic catecholamine neurotransmitter, which is an equal mixture of the left-handed (L-, with activity) and right-handed (D-, with very low or no activity) stereoisomers. DL-Norepinephrine hydrochloride after being labeled with tritium can be used as a tracer for the research on Parkinson's disease.
    DL-Norepinephrine-d3 hydrochloride
  • HY-130675
    (±)15-HEPE

    (±)15-hydroxyeicosapentaenoic acid; 15-OHEPA

    		 Lipoxygenase Bacterial Metabolic Disease
    (±)15-HEPE is a racemic mixture of the monohydroxy fatty acids 15(R)-HEPE and 15(S)-HEPE (HY-130675A). (±)15-HEPE is active against P. acnes and S. aureus (MICs = 128 and 512 mg/L, respectively). It inhibits aggregation of isolated rat neutrophils induced by the formyl peptide receptor agonist fMLP (IC50 = 4.7 µM). Bronchoalveolar lavage fluid (BALF) levels of (±)15-HEPE are increased in patients with allergic asthma or COVID-19.
    (±)15-HEPE
  • HY-B0399A
    (±)-Carnitine

    DL-Carnitine; DL-Levocarnitine

    		 Mitochondrial Metabolism Metabolic Disease
    (±)-Carnitine (DL-Carnitine) is an orally effective racemic mixture of L-Carnitine (HY-B0399) and D-Carnitine. (±)-Carnitine elevates the mitochondrial NAD +/NADH ratio in the presence of 1,3-butanediol (HY-77490A). (±)-Carnitine does not increase glucose and urea production from L-glutamine, but stimulates propionate gluconeogenesis in rat renal cortical slices, and significantly reduces hepatic ketone body levels in rats fed a diet containing 30% high fat plus 20% 1,3-butanediol .
    (±)-Carnitine
  • HY-100869B
    MM-589 (racemic mixture ) TFA

    		WDR5 Cancer
    MM-589 (racemic mixture) TFA, is a racemic mixture of MM-589 TFA (HY-100869A). MM-589 TFA is a potent inhibitor of WD repeat domain 5 (WDR5) and mixed lineage leukemia (MLL) protein-protein interaction. MM-589 binds to WDR5 with an IC50 of 0.90 nM and inhibits the MLL H3K4 methyltransferase activity with an IC50 of 12.7 nM .
    MM-589 (racemic mixture ) TFA
  • HY-B2236A
    DL-Lysine monohydrate

    (±)-2,6-Diaminocaproic acid monohydrate

    		 Biochemical Assay Reagents Metabolic Disease
    DL-Lysine monohydrate is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins .
    DL-Lysine monohydrate
  • HY-145263A
    VD2173 epimer-1

    		Ser/Thr Protease Cancer
    VD2173 epimer-1 is a racemic mixture of VD2173 (HY-145263) .
    VD2173 epimer-1
  • HY-W295313
    (+)-Neoisomenthol

    		Drug Derivative Others
    (+)-Neoisomenthol is one of the isomers of (±)-Neoisomenthol. (±)-Neoisomenthol is a compound that belongs to the class of monoterpenes. (±)-Neoisomenthol is a volatile constituent of Mentha arvensis with a peppermint odor and taste. It is a chiral compound, existing as a racemic mixture of two enantiomers, (+)-neoisomenthol and (-)-neoisomenthol.
    (+)-Neoisomenthol
  • HY-106601A
    Picenadol hydrochloride

    LY-150720 hydrochloride

    		 Opioid Receptor Neurological Disease
    Picenadol (LY-150720) hydrochloride is an opioid mixed agonist-antagonist analgesic. Picenadol hydrochloride is an external racemic mixture, where its d-isomer (LY136596) is a potent μ-opioid receptor agonist, and the l-isomer (LY136595) is a weak μ-receptor competitive antagonist, which can inhibit the agonist effect and reduce the risk of dependence. Picenadol hydrochloride has anticholinergic activity .
    Picenadol hydrochloride
  • HY-120109
    13-HODE methyl ester

    		Endogenous Metabolite Cancer
    13-HODE methyl ester, a racemic mixture of 13(R)-HODE methyl ester and 13(S)-HODE methyl ester, is a 15-lipoxygenase metabolite of Linoleic acid .
    13-HODE methyl ester
  • HY-107370A
    (Rac)-Atomoxetine hydrochloride

    (Rac)-Tomoxetine hydrochloride; (Rac)-LY 139603

    		 Serotonin Transporter Sodium Channel Metabolic Disease Cancer
    (Rac)-Atomoxetine hydrochloride ((Rac)-Tomoxetine (hydrochloride); (Rac)-LY 139603) is the racemic mixture of Atomoxetine hydrochloride (HY-17385). Atomoxetine hydrochloride is a selective noradrenaline reuptake inhibitor with Ki values of 5, 77 and 1451 nM for norepinephrine (NE), serotonin (5-HT) and dopamine (DA) transporters, respectively. Atomoxetine hydrochloride increases of DAEX and NEEX in the PFC and enhances catecholaminergic neurotransmission. Atomoxetine hydrochloride is a potent Na + channels (VGSCs) blocker. Atomoxetine hydrochloride can be used for attention-deficit hyperactivity disorder (ADHD) research .
    (Rac)-Atomoxetine hydrochloride
  • HY-118590A
    ICRF-196

    		Topoisomerase DNA/RNA Synthesis Apoptosis Fungal Infection Cardiovascular Disease Inflammation/Immunology Cancer
    ICRF-196 is an racemic mixture of the (S,S)- and (R,R)-isomers of ICRF-193 (HY-118590). ICRF-193 is a DNA Topoisomerase II inhibitor. ICRF-193 can inhibit DNA syntheses and induces apoptosis. ICRF-193 exhibits anti-cancer and anti-inflammation effects. ICRF-193 shows cardioprotective effect against anthracycline toxicity to cardiomyocytes. ICRF-193 can be used for the researches of cancer, infection, inflammation and cardiovascular disease, such as acute promyelocytic leukemia .
    ICRF-196
  • HY-10011B
    (Rac)-SCH 563705

    		CXCR Inflammation/Immunology Endocrinology
    (Rac)-SCH 563705 is a racemic mixture of SCH 563705 (HY-10011). SCH 563705 (compound 16) is a potent and orally active CXCR2 and CXCR1 antagonist with IC50 values ​​of 1.3 nM and 7.3 nM and Ki values ​​of 1 nM and 3 nM, respectively .
    (Rac)-SCH 563705
  • HY-12993A
    RSV604 racemate

    A-60444 racemate

    		 RSV Others
    RSV604 (A-60444) racemate is a racemic mixture, shows less potency against strains of respiratory syncytial virus (RSV) than the S-isomer.
    RSV604 racemate
  • HY-172009
    8-Amino-7-oxononanoic acid hydrochloride

    		Drug Isomer Others
    8-Amino-7-oxononanoic acid hydrochloride is a racemic mixture of 8(R)-KAPA and the vitamer of biotin 8(S)-KAPA.
    8-Amino-7-oxononanoic acid hydrochloride
  • HY-W178699
    (±)-Neoisomenthol

    		Drug Derivative Others
    (±)-Neoisomenthol is a monoterpene. (±)-Neoisomenthol is a volatile constituent of Mentha arvensis with a peppermint odor and taste. (±)-Neoisomenthol is a chiral compound, existing as a racemic mixture of two enantiomers, (+)-Neoisomenthol and (-)-Neoisomenthol .
    (±)-Neoisomenthol
  • HY-W010143
    (R,S)-Norcotinine

    (Rac)-Norcotinine

    		 Drug Metabolite Cardiovascular Disease
    (R,S)-Norcotinine ((Rac)-Norcotinine) is the racemic mixture of Norcotinine. (R,S)-Norcotinine is a biomarker of secondhand smoke exposure and is associated with the toxic mechanisms of secondhand smoke on cardiovascular development .
    (R,S)-Norcotinine
  • HY-I0635
    (Rac)-Apremilast

    (Rac)-CC-10004

    		 Phosphodiesterase (PDE) Inflammation/Immunology
    (Rac)-Apremilast ((Rac)-CC-10004) is the racemic mixture of Apremilast. (Rac)-Apremilast has anti-inflammatory properties and can be used for research on inflammatory diseases, such as psoriasis .
    (Rac)-Apremilast
  • HY-130310B
    (±)11-HEDE

    11-hydroxy-12,14-Eicosadienoic acid

    		 COX Metabolic Disease
    (±)11-HEDE is a racemic mixture of the monohydroxy fatty acids 11(S)-HEDE and 11(R)-HEDE. 11-HEDE is formed from eicosadienoic acid by cyclooxygenase (COX) and in macrophages.
    (±)11-HEDE
  • HY-112438A
    rac-MF-094

    		Deubiquitinase Cancer
    rac-MF-094 is the racemic mixture of MF-094 (HY-112438). MF-094 is a potent and selective USP30 inhibitor with an IC50 of 120 nM. MF-094 increases protein ubiquitination and accelerates mitophagy .
    rac-MF-094
  • HY-Y1315R
    DL-Tartaric acid (Standard)

    		Biochemical Assay Reagents Reference Standards Others
    DL-Tartaric acid (Standard) is the analytical standard of DL-Tartaric acid. This product is intended for research and analytical applications. DL-Tartaric acid is a non-racemic mixture of L- and D-tartaric acid with antioxidant activity. 14C-labeled DL-Tartaric acid is nephrotoxic .
    DL-Tartaric acid (Standard)
  • HY-B0105BS
    Levoketoconazole-d3

    (-)-Ketoconazole-d3; (-)-Ketoconazol-d3; (-)-R 41400-d3

    		 Isotope-Labeled Compounds Fungal Infection Inflammation/Immunology
    (-)-Ketoconazole-d3 is deuterium labeled (-)-Ketoconazole. (-)-Ketoconazole ((-)-R 41400) is one of the enantiomer of Ketoconazole. Ketoconazole is a racemic mixture of two enantiomers, levoketoconazole ((2S,4R)-(−)-ketoconazole) and dextroketoconazole ((2R,4S)-(+)-ketoconazole).
    Levoketoconazole-d3
  • HY-B2236S3
    DL-Lysine-15N2 hydrochloride

    (±)-2,6-Diaminocaproic acid-15N2 hydrochloride

    		 Isotope-Labeled Compounds Metabolic Disease
    DL-Lysine- 15N2 hydrochloride ((±)-2,6-Diaminocaproic acid- 15N2 hydrochloride) is 15N labeled DL-Lysine (HY-B2236). DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins.
    DL-Lysine-15N2 hydrochloride
  • HY-B2236S1
    DL-Lysine-13C6 hydrochloride

    (±)-2,6-Diaminocaproic acid-13C6 hydrochloride

    		 Isotope-Labeled Compounds Metabolic Disease
    DL-Lysine- 13C6 hydrochloride ((±)-2,6-Diaminocaproic acid- 13C6 hydrochloride) is 13C-labeled DL-Lysine (HY-B2236). DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins.
    DL-Lysine-13C6 hydrochloride

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: